Business
ARECOR 2021 ANNUAL REPORT AND NOTICE OF AGM
ARECOR 2021 ANNUAL REPORT AND NOTICE OF AGM.
About this update from Arecor Therapeutics Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 5943J\n Arecor Therapeutics PLC\n 27 April 2022\n \n \n \n \n Arecor Therapeutics plc\n \n \n (\"Arecor\" or the \"Group\")\n \n \n \n \n \n POSTING OF ARECOR 2021 ANNUAL REPORT AND NOTICE OF AGM\n \n \n Cambridge\n , UK, \n 27\n April 2022. Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today's therapies to enable healthier lives, \n announces that it has today published and posted to shareholders the Annual Report and Accounts for the year ended 31 December 2021 and Notice of the Annual General Meeting (\"AGM\") which will be held at \n Covington & Burling LLP, 22 Bishopsgate, London EC2N 4BQ\n , on 23 May 2022 at 1.00 p.m. (BST).\n \n \n \n \n \n The Annual Report and Accounts and notice of AGM are also available to view on, and download from, the Company's website at \n \n www.arecor.com/investor-centre/\n \n . \n \n \n \n This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 (MAR)\n \n \n \n -ENDS-\n \n \n For more information, please contact:\n \n \n \n Arecor Therapeutics plc\n \n \n \n www.arecor.com\n \n \n \n \n \n Dr Sarah Howell, Chief Executive Officer\n \n \n Tel: +44 (0) 1223 426060\n Email: [email protected]\n \n \n \n \n \n \n \n \n \n \n \n \n Susan Lowther, Chief Financial Officer\n \n \n Tel: +44 (0) 1223 426060\n Email: [email protected]\n \n \n \n \n \n \n \n \n \n \n \n \n Mo Noonan, Communications\n \n \n Tel: +44 (0) 7876 444977\n Email: [email protected]\n \n \n \n \n \n \n \n \n \n \n \n \n \n Panmure Gordon (UK) Limited (NOMAD and Broker)\n Freddy Crossley, Emma Earl (Corporate Finance)\n Rupert Dearden (Corporate Broking)\n \n \n Tel: +44 (0) 20 7886 2500\n \n \n \n \n \n \n \n \n \n \n \n \n \n Consilium Strategic Communications\n \n \n \n \n \n \n \n Chris Gardner, David Daley, Angela Gray\n \n \n Tel: +44 (0) 20 3709 5700\n Email: [email protected]\n \n \n \n \n Notes to Editors\n \n About Arecor\n Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary formulation technology platform, Aresta...